900% move: CHM.CN Waverunner Capital CNQ at C$0.05 on 19 Jan 2026: monitor volume
The CHM.CN stock recorded a 900.00% intraday move to C$0.05 on 19 Jan 2026 on the CNQ exchange in Canada, marking it as a high-volume mover during market hours. We see this spike against a low trading base and an average volume of 28,908.00 shares. The move follows the June 2024 rebrand from Chemistree Technology to Waverunner Capital Inc., and it raises questions about liquidity, news flow, and short-term catalysts for traders.
Price action and catalyst summary for CHM.CN stock
CHM.CN stock rose 900.00% from a previous close of C$0.005 to C$0.05 on 19 Jan 2026. The day range was C$0.05–C$0.05 and the one-year range is C$0.05–C$0.10. Volume print is incomplete in feeds, but price averaged above the 50-day mean of C$0.04. Traders should link the spike to low float dynamics and episodic buying rather than steady institutional demand.
Fundamentals and valuation: CHM.CN stock financial snapshot
Waverunner Capital Inc. reports EPS -0.01 and PE -5.00, with market cap at C$37,211,650.00. Shares outstanding total 744,233,000.00. Book value per share is negative at -0.11, and cash per share is 0.01. These metrics reflect an early-stage venture profile and negative profitability. Investors must weigh small-cap volatility against venture exposure in healthcare and renewables.
Liquidity, technicals and trading risks for CHM.CN stock
Average volume sits at 28,908.00 shares, which creates sharp moves on modest demand. Price averages are 50-day C$0.04 and 200-day C$0.05. The current bid-ask depth can be thin, raising slippage risk. We flag high volatility, possible quote gaps, and limited institutional coverage as primary trading risks.
Meyka AI grade and model view on CHM.CN stock
Meyka AI rates CHM.CN with a score out of 100: 61.07 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The score combines fundamentals and market signals but is not investment advice. Meyka AI’s grade highlights moderate quality versus small-cap peers in Healthcare.
Forecasts, price targets and analyst-style CHM.CN stock outlook
Meyka AI’s forecast model projects a range of outcomes for CHM.CN stock. We set a base-case target of C$0.07, a bull target of C$0.15, and a bear scenario of C$0.02. Those translate to implied moves of +40.00%, +200.00%, and -60.00% versus the current C$0.05. Forecasts are model-based projections and not guarantees.
Catalysts, sector context and short-term strategy for CHM.CN stock
Key catalysts include fresh funding, asset sales, or equity-backed investments in renewables and biotech holdings. The Healthcare sector shows mixed performance and negative recent returns, increasing idiosyncratic risk for small names. For high-volume traders we recommend limits, clear stop rules, and scaled position sizing given thin liquidity.
Final Thoughts
CHM.CN stock delivered a striking intraday move to C$0.05 on 19 Jan 2026, driven by low liquidity and episodic buying rather than improved fundamentals. Our fundamental review shows EPS -0.01, PE -5.00, negative book value, and market cap C$37,211,650.00, supporting a cautious stance. Meyka AI rates CHM.CN with a score out of 100 at 61.07 (Grade B, Suggestion: HOLD) and flags liquidity as the primary risk. Meyka AI’s forecast model projects a base-case of C$0.07 (+40.00%), a bull case of C$0.15 (+200.00%), and a bear case of C$0.02 (-60.00%). These targets reflect volatility, limited cash per share, and the company’s venture-style asset mix. Traders should treat the move as a high-risk trading event and size positions accordingly. For more company details visit the Waverunner website and financial profile Waverunner Capital site and a market data page Financial Modeling Prep, and use Meyka AI tools for live scanning and order planning. Forecasts are model-based projections and not guarantees.
FAQs
What caused the CHM.CN stock spike on 19 Jan 2026?
The CHM.CN stock spike reflects thin liquidity, episodic buying, and a low float structure after its rebrand. There was no confirmed major news release. Average volume is only 28,908.00, so small trades can move price materially.
What is Meyka AI’s rating for CHM.CN stock?
Meyka AI rates CHM.CN with a score out of 100 at 61.07, graded B with a HOLD suggestion. The grade factors in benchmarks, sector and financial metrics and is for informational use only.
What are realistic price targets for CHM.CN stock?
Meyka AI’s forecast model projects a base-case C$0.07, bull C$0.15, and bear C$0.02. Versus the current C$0.05, these imply +40.00%, +200.00%, and -60.00% respectively. Models are not guarantees.
Should traders buy CHM.CN stock after this move?
Given CHM.CN stock’s thin liquidity, negative earnings, and volatile profile, traders should use small, defined positions and strict stops. The stock suits speculative, short-term trades rather than core allocation.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
